loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X

Technical details about Fasedienol, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: 23062-06-8, Fasedienol, Aloradine, 4,16-androstadien-3-beta-ol, 4,16-androstadien-3beta-ol, Dtw1nj7ijh
Molecular Formula
C19H28O
Molecular Weight
272.4  g/mol
InChI Key
NYVFCEPOUVGTNP-DYKIIFRCSA-N
FDA UNII
DTW1NJ7IJH

PH94B is being developed by Pherin Pharmaceuticals, Inc. for the treatment of social phobias (generalized anxiety disorder). It is a member of a new family of pharmaceutical compounds called vomeropherins.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3S,8S,9S,10R,13R,14S)-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol
2.1.2 InChI
InChI=1S/C19H28O/c1-18-9-3-4-16(18)15-6-5-13-12-14(20)7-11-19(13,2)17(15)8-10-18/h3,9,12,14-17,20H,4-8,10-11H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1
2.1.3 InChI Key
NYVFCEPOUVGTNP-DYKIIFRCSA-N
2.1.4 Canonical SMILES
CC12CCC3C(C1CC=C2)CCC4=CC(CCC34C)O
2.1.5 Isomeric SMILES
C[C@]12CC[C@H]3[C@H]([C@@H]1CC=C2)CCC4=C[C@H](CC[C@]34C)O
2.2 Other Identifiers
2.2.1 UNII
DTW1NJ7IJH
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 23062-06-8

2. Fasedienol

3. Aloradine

4. 4,16-androstadien-3-beta-ol

5. 4,16-androstadien-3beta-ol

6. Dtw1nj7ijh

7. (3s,8s,9s,10r,13r,14s)-10,13-dimethyl-2,3,6,7,8,9,10,11,12,13,14,15-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol

8. Androsta-4,16-dien-3-ol, (3b)-

9. (3s,8s,9s,10r,13r,14s)-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a]phenanthren-3-ol

10. (3as,3bs,7s,9ar,9bs,11ar)-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,7h,8h,9h,9ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-ol

11. 4-androstadienol

12. Unii-dtw1nj7ijh

13. Fasedienol [inn]

14. Aloradine [who-dd]

15. Ph94b

16. Androsta-4,16-dien-3beta-ol

17. Schembl4075431

18. Androsta-4,16-diene-3beta-ol

19. Dtxsid901032322

20. (3b)-androsta-4,16-dien-3-ol

21. Yaa06206

22. Mfcd00271236

23. Zinc34031047

24. Akos028109412

25. As-60043

26. Androsta-4,16-dien-3-ol, (3.beta.)-

27. Hy-145567

28. Cs-0376082

29. Q20707597

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 272.4 g/mol
Molecular Formula C19H28O
XLogP34.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count1
Rotatable Bond Count0
Exact Mass272.214015512 g/mol
Monoisotopic Mass272.214015512 g/mol
Topological Polar Surface Area20.2 Ų
Heavy Atom Count20
Formal Charge0
Complexity476
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Intended for the acute treatment of social phobia.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Vomeropherin compounds are directly delivered to the nasal passages using either a metered nasal spray or a metered nasal aerosol. By virtue of the chemoreceptors location in the nasal passages, direct connections to the hypothalamus and limbic system and the ability of our compounds to act locally, vomeropherins do not need to achieve systemic absorption and distribution. This provides a significant therapeutic advantage over traditional therapeutics targeted at the hypothalamus and limbic system that require access to systemic circulation and must cross the blood-brain barrier followed by uptake into the brain to exert effects.


5.2 Absorption, Distribution and Excretion

Absorption

Absorbed following nasal administration.


5.3 Mechanism of Action

There is little information available on the mechanism of action of vomeropherins. These compounds are delivered to the nasal passages and bind to chemoreceptors that in turn affect the hypothalamus and the limbic system.


Post Enquiry
POST ENQUIRY